Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2011
12/08/2011WO2011153168A1 Pharmaceutical compositions of ibuprofen and an h2 receptor antagonist
12/08/2011WO2011152671A2 Pharmaceutical composition for the prevention or treatment of inflammatory diseases or immune diseases containing ramalin
12/08/2011WO2011152508A1 Optically active dibenzylamine derivative, and manufacturing method for same
12/08/2011WO2011152503A1 Treatment drug for autoimmune diseases and allergic diseases
12/08/2011WO2011152485A1 Novel 4,5-fused pyrimidine derivative
12/08/2011WO2011152351A1 Purinone derivative
12/08/2011WO2011152297A1 Solid dispersion comprising triazole compound
12/08/2011WO2011152100A1 Mesenchymal stem cell inducer, and method for induction of mesenchymal stem cell
12/08/2011WO2011151423A1 Substituted isoquinolines and their use as tubulin polymerization inhibitors
12/08/2011WO2011151358A1 2 -amino- pyrimidine derivatives useful as inhibitors of jnk
12/08/2011WO2011151357A1 Inhibitors of jnk
12/08/2011WO2011151251A1 New ccr2 antagonists
12/08/2011WO2011150682A1 4-hydroxyquinoline-3-amide derivatives and preparation methods and uses thereof
12/08/2011WO2011125070A3 Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof
12/08/2011WO2011113895A3 Characterization and validation of inhibitors and ligands of dipeptidyl aminopeptidase iv (dp iv)
12/08/2011WO2011103666A8 Modulation of cytokine-induced chronic inflammatory responses
12/08/2011WO2010128401A9 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
12/08/2011US20110301228 Gene therapy vector for treatment of steroid glaucoma
12/08/2011US20110301225 Compounds and Methods for Reducing the Recruitment and/or Migration of Polymorphonuclear Cells
12/08/2011US20110301217 Selective Glycosidase Inhibitors and Uses Thereof
12/08/2011US20110301215 Inhibitors of plasma kallikrein
12/08/2011US20110301214 Pharmaceutical compositions comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
12/08/2011US20110301211 Antagonists of lysophosphatidic acid receptors
12/08/2011US20110301171 Inhibitors of JNK
12/08/2011US20110301170 Inhibitors of JNK
12/08/2011US20110301168 Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors
12/08/2011US20110301163 Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders
12/08/2011US20110301161 Benzimidazole inhibitors of leukotriene production
12/08/2011US20110301160 Inhibitors of P38 and Methods of Using the Same
12/08/2011US20110301157 Bicyclic amides as kinase inhibitors
12/08/2011US20110301156 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use Thereof to Treat Pain and Other Conditions
12/08/2011US20110301154 Sigma receptors ligands with anti-apoptotic and/or pro-apoptotic properties, over cellular mechanisms, exhibiting prototypical cytoprotective and also anticancer activity
12/08/2011US20110301152 Nicotinic receptor agonists for the treatment of inflammatory diseases
12/08/2011US20110301149 Compositions and methods for treating alcohol use disorders, pain and other diseases
12/08/2011US20110301145 Pyridazinones, method of making, and method of use thereof
12/08/2011US20110301144 Kinase Antagonists
12/08/2011US20110301134 Alkyne antagonists of lysophosphatidic acid receptors
12/08/2011US20110301133 Compositions of protein receptor tyrosine kinase inhibitors
12/08/2011US20110301131 Drug Delivery Implants and Processes for Their Preparation
12/08/2011US20110301129 Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
12/08/2011US20110301116 Nsaids-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof
12/08/2011US20110301112 Fused ring thrombin receptor antagonists
12/08/2011US20110301111 Cyclic adenosine monophosphates for reducing the formation of adhesions
12/08/2011US20110301109 Phenylpyrimidone Compounds, the Pharmaceutical Compositions, Preparation Methods and Uses Thereof
12/08/2011US20110301107 Derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
12/08/2011US20110301100 Pharmaceutical Compositions Comprising Polyethylene Glycol Having a Molecular Weight of Less Than 600 Daltons
12/08/2011US20110301096 Prodrug of an ice inhibitor
12/08/2011US20110301077 Method for production of lactoferrin
12/08/2011US20110300245 Topical, palatable, anti-inflammatory and analgesic for specific application to intraoral, gingival and extraoral areas correlated with, and related to, the trigeminal nerve and its nerve branches and plexus. To mitigate, attenuate or prevent migraine-type headache, cluster-type headache, tension-type headache, post-traumatic headache, atypical facial pain and cervical muscle spasm as well as other idiopathic head or facial pain or discomfort, associated with, or exacerbated by, inflammation
12/08/2011US20110300244 Water-soluble extracts of artemisia dracunculus (tarragon) for improvement of glucose metabolism
12/08/2011US20110300240 Cajanus extracts and glucosamine for inflammatory disorders
12/08/2011US20110300216 Chewable, swallowable and effervescent solid dosage form for oral delivery of pharmaceutical actives
12/08/2011US20110300210 Controlled release nanoparticulate clozapine compositions
12/08/2011US20110300199 Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions
12/08/2011US20110300195 Ophthalmic Compositions Comprising Calcineurin Inhibitors or mTOR Inhibitors
12/08/2011US20110300182 Nucleic acid drug for treatment of allergic disease
12/08/2011US20110300167 Cxcr5 receptor compounds
12/08/2011US20110300165 Substituted isoxazole compounds
12/08/2011US20110300160 Sulfation of wnt pathway proteins
12/08/2011US20110300157 Metalloproteinase 9 and metalloproteinase 2 binding proteins
12/08/2011US20110300152 Compositions and methods for modulating cell-cell fusion via intermediate-conductance calcium-activated potassium channels
12/08/2011US20110300151 Uses and compositions for treatment of hidradenitis suppurativa (hs)
12/08/2011US20110300148 Il-4-derived peptides for modulation of the chronic inflammatory response and treatment of autoimmune diseases
12/08/2011US20110300145 Interferon Alpha Antibodies And Their Uses
12/08/2011US20110300142 Use of zeburaline for the treatment of autoimmune diseases or immune rejection of transplants
12/08/2011US20110300136 Therapy of autoimmune disease in a patient with an inadequate response to a tnf-alpha inhibitor
12/08/2011US20110300135 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
12/08/2011US20110300125 Compositions and methods for combined therapy of disease
12/08/2011US20110300119 Methods of enriching and using regulatory t cells
12/08/2011CA2801509A1 Treatment drug for autoimmune diseases and allergic diseases
12/08/2011CA2801417A1 Optically active dibenzylamine derivative, and method for preparing thereof
12/08/2011CA2800523A1 Purinone derivative
12/08/2011CA2799817A1 Inhibitors of jnk
12/08/2011CA2799653A1 Substituted isoquinolines and their use as tubulin polymerization inhibitors
12/08/2011CA2799328A1 2 -amino- pyrimidine derivatives useful as inhibitors of jnk
12/07/2011EP2392584A1 Crystalline Ciclesonide Methanol Solvate Form C
12/07/2011EP2392352A2 Cd93 or use of soluble fragment thereof
12/07/2011EP2392338A1 Prophylactic or therapeutic agent for diseases associated with abnormal bone metabolism
12/07/2011EP2392328A1 Compounds for modulating TRPV3 Function
12/07/2011EP2391627A2 Bicyclic pyrazolo-heterocycles
12/07/2011EP2391619A1 Heteroaryls and their use as pi3k inhibitors
12/07/2011EP2391617A1 Azetidines as histamine h3 receptor antagonists
12/07/2011EP2391360A2 Method of synergistically enhancing the therapeutic efficacy and safety of medications through a combination therapy
12/07/2011EP1957477B1 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors
12/07/2011CN202060937U 治疗脐疝的婴幼儿连体衣 Treatment of umbilical hernia in infants leotard
12/07/2011CN1977966B 一种祛风逐瘀膏 One kind of dispelling stasis cream
12/07/2011CN1960731B 调节炎性和转移过程的方法 Inflammatory and method transfer process
12/07/2011CN1494425B 用作治疗剂的羧酰胺衍生物 As therapeutic agents carboxamide derivatives
12/07/2011CN102272129A 硫酸化c-糖苷及其分离方法以及合成方法 C- glucoside sulfated and separation and synthesis method
12/07/2011CN102271707A 单域抗原结合性分子的制剂 Single domain antigen-binding molecule preparation
12/07/2011CN102271685A 鉴定发展成器官功能衰竭的风险提高的危重患者的方法及用于其治疗的化合物 Identification develop into an increased risk of organ failure in critically ill patients for their treatment methods and compounds
12/07/2011CN102271668A 表观遗传调控的小分子调节剂和其治疗应用 Epigenetic regulation of small molecule modulators and their therapeutic applications
12/07/2011CN102269752A 一种药物组合物制剂的检测方法 A detection method for the preparation of pharmaceutical compositions
12/07/2011CN102268094A Modified transferrin fusion proteins
12/07/2011CN102268085A 重组细胞球蛋白在延缓皮肤衰老中的应用 Globulin used in recombinant cells in aging skin
12/07/2011CN102268070A 基质金属蛋白酶-9多肽抑制剂2及其应用 Peptide inhibitor of matrix metalloproteinase-9 and its application 2
12/07/2011CN102268069A 基质金属蛋白酶-9多肽抑制剂4及其应用 Peptide inhibitor of matrix metalloproteinase-9 and its application 4
12/07/2011CN102268068A 基质金属蛋白酶-9多肽抑制剂1及其应用 Peptide inhibitor of matrix metalloproteinase-9 and its application 1
12/07/2011CN102268067A 一种含ldv序列短肽的聚乙二醇化衍生物 Ldv short peptide sequence containing polyethylene glycol derivatives
12/07/2011CN102267988A 2-氨基嘧啶衍生物及其医药用途 2-amino-pyrimidine derivatives and pharmaceutical use